Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy

References

• GISSI-Prevention Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico)Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevention trialLancet199935444745510465168
   PubMed Web of Science ®Google Scholar
• BhatnagarDDurringtonPNOmega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complicationsInt J Clin Pract20035730531412800463
   PubMed Web of Science ®Google Scholar
• MarchioliRLevantesiGMacchiaAGISSI-Prevenzione Investigators. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trialJ Membr Biol200520611712816456722
   PubMed Web of Science ®Google Scholar
• MathersCDSteinCMa FatMThe Global Burden of Disease 2000 Study (version 2): Methods and Results Discussion Paper 50 Geneva: Global Program on Evidence for Health PolicyWorld Health Organization2002http://www.who.int/infobase IBRef: 19998.
   Google Scholar
• MichaudCMMurrayCJBloomBRBurden of disease-implications for future researchJAMA2001285553553911176854
   PubMed Web of Science ®Google Scholar
• YusufSReddySOunpuuSAnandSGlobal burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanizationCirculation20011042746275311723030
   PubMed Web of Science ®Google Scholar
• YusufSReddySOunpuuSAnandSGlobal burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategiesCirculation20011042855286411733407
   PubMed Web of Science ®Google Scholar
• KannelWBMcGeeDLDiabetes and cardiovascular disease: the Framingham studyJAMA197924120352038430798
   PubMed Web of Science ®Google Scholar
• StamlerJVaccaroONeatonJDWentworthDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care1993164344448432214
   PubMed Web of Science ®Google Scholar
• DurringtonPDyslipidaemiaLancet200336271773112957096
   PubMed Web of Science ®Google Scholar
• Kita ChunAMcGeeSRBedside diagnosis of coronary artery disease: a systematic reviewAm J Med200411733434315336583
   PubMed Web of Science ®Google Scholar
• PatelJVLimHSGunarathneAEthnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitusQJM200810123123618204065
   PubMed Web of Science ®Google Scholar
• CastelliWPGarrisonRJWilsonPWAbbottRDKalousdianSKannelWBIncidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA1986256283528383773200
   PubMed Web of Science ®Google Scholar
• KannelWBSorliePMcNamaraPMPrognosis after initial myocardial infarction: the Framingham studyAm J Cardiol1979445359453046
   PubMed Web of Science ®Google Scholar
• KjekshusJDunselmanPBlideskogMA statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristicsEur J Heart Fail200571059106916227145
   PubMed Web of Science ®Google Scholar
• RauchhausMClarkALDoehnerWThe relationship between cholesterol and survival in patients with chronic heart failureJ Am Coll Cardiol2003421933194014662255
   PubMed Web of Science ®Google Scholar
• HorwichTBHamiltonMAMaclellanWRFonarowGCLow serum total cholesterol is associated with marked increase in mortality in advanced heart failureJ Card Fail2002821622412397569
   PubMed Web of Science ®Google Scholar
• BurrMLFehilyAMGilbertJFEffects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)Lancet198927577612571009
   PubMed Web of Science ®Google Scholar
• MarchioliRBarziFBombaEGISSI-Prevenzione InvestigatorsEarly protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-PrevenzioneCirculation20021051897190311997274
   PubMed Web of Science ®Google Scholar
• MacchiaALevantesiGFranzosiMGGISSI Prevenzione InvestigatorsLeft ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acidsEur J Heart Fail2005790490916087142
   PubMed Web of Science ®Google Scholar
• YokoyamaMOrigasaHMatsuzakiMJapan EPA lipid intervention study (JELIS) InvestigatorsEffects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysisLancet20073691090109817398308
   PubMed Web of Science ®Google Scholar
• StuderMBrielMLeimenstollBGlassTRBucherHCEffect of different antilipidemic agents and diets on mortality: a systematic reviewArch Intern Med200516572573015824290
   PubMed Web of Science ®Google Scholar
• HobbsFDRKenkreJRoalfeAKDavisRCHareRDaviesMKImpact of heart failure and left ventricular systolic dysfunction on quality of lifeEur Heart J2002231867187612445536
   PubMed Web of Science ®Google Scholar
• HoKKAndersonKMKannelWBGrossmanWLevyDSurvival after the onset of congestive heart failure in Framingham Heart Study subjectsCirculation1993881071158319323
   PubMed Web of Science ®Google Scholar
• SuttonGCEpidemiological aspects of heart failureAm Heart J1990120153815402248209
   PubMed Web of Science ®Google Scholar
• BonneauxLBarendregtJJMeeterKBonselGJVan der MaasPJEstimating clinical morbidity due to ischaemic heart disease and congestive heart failure: the future rise of heart failureAm J Public Health19948420288279606
   PubMed Web of Science ®Google Scholar
• McMurrayJJStewartSEpidemiology, aetiology and prognosis of heart failureHeart20008359660210768918
   PubMed Web of Science ®Google Scholar
• SpencerFMeyerTGoldbergRJTwenty year trends (1975–1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspectiveJ Am Coll Cardiol1999341378138710551682
   PubMed Web of Science ®Google Scholar
• NicodPGilpinEDittrichHInfluence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarctionAm J Cardiol198861116511713376878
   PubMedGoogle Scholar
• EmanuelssonHKarlsonWHerlitzJCharacteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failureEur Heart J1994157617688088264
   PubMedGoogle Scholar
• National Institute for Clinical ExcellenceChronic heart failure: management of chronic heart failure in adults in primary and secondary careClinical Guideline 5. London: National Institute for Clinical Excellence; July 2003. URL http://guidance.nice.org.uk/cg5 Accessed 08/08/2008
   Google Scholar
• MacchiaALevantesiGFranzosiMGGISSI-Prevenzione InvestigatorsLeft ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acidsEur J Heart Fail200590490916087142
   PubMedGoogle Scholar
• Gissi-HF InvestigatorsTavazziLMaggioniAPMarchioliREffect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialLancet20083721223123018757090
   PubMed Web of Science ®Google Scholar
• Gissi-HF InvestigatorsTavazziLMaggioniAPMarchioliREffect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialLancet20083721231123918757089
   PubMed Web of Science ®Google Scholar
• LombardiFMäkikallioTHMyerburgRJHuikuriHVSudden cardiac death: role of heart rate variability to identify patients at riskCardiovasc Res20015021021711334824
   PubMed Web of Science ®Google Scholar
• SteinPKKleigerREInsights from the study of heart rate variabilityAnn Rev Med19995024926110073276
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and ElectrophysiologyHeart rate variability: standards of measurement, physiological interpretation, and clinical useCirculation199693104310658598068
   PubMed Web of Science ®Google Scholar
• ChristensenJHSkouHAFogLMarine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiographyCirculation200110365165711156875
   PubMed Web of Science ®Google Scholar
• ChristensenJHGustenhoffPKorupEn-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial [Danish]Ugeskr Laeger1997159552555299312922
   PubMedGoogle Scholar
• HamaadAKaeng LeeWLipGYMacFadyenRJOral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patientsCardiovasc Drugs Ther20062035936417089085
   PubMed Web of Science ®Google Scholar
• ChristensenJHChristensenMSDyerbergJHeart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acidsAm J Clin Nutr19997033133710479194
   PubMed Web of Science ®Google Scholar
• PepeSMcLennanPLCardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile functionCirculation20021052303230812010914
   PubMed Web of Science ®Google Scholar
• BillmanGEKangJXLeafAPrevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogsCirculation1999992452245710318669
   PubMed Web of Science ®Google Scholar
• MozaffarianDPsatyBMRimmEBFish intake and risk of incident atrial fibrillationCirculation200411036837315262826
   PubMed Web of Science ®Google Scholar
• OmmenSROdellKAStantonMSAtrial arrythmias after cardiothoracic surgeryN Engl J Med1997336142914349145681
   PubMed Web of Science ®Google Scholar
• CaloLBianconiLColivicchiFN-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass sugeryJ Am Coll Cardiol2005451723172815893193
   PubMed Web of Science ®Google Scholar
• RaittMHConnorWEMorrisCFish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trialJAMA20052932884289115956633
   PubMed Web of Science ®Google Scholar
• NodariSMetraMMilesiGThe role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathyCardiovasc Drugs Ther20092351518982439
   PubMed Web of Science ®Google Scholar
• BrouwerIAZockPLCammAJfor the SOFA Study GroupEffect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators: The Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) Randomized TrialJAMA20062952613261916772624
   PubMed Web of Science ®Google Scholar
• LeafAAlbertCMJosephsonMFatty Acid Antiarrhythmia Trial InvestigatorsPrevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intakeCirculation20051122762276816267249
   PubMed Web of Science ®Google Scholar
• MozaffarianDPsatyBMRimmEBFish intake and risk of incident atrial fibrillationCirculation200411036833715262826
   PubMed Web of Science ®Google Scholar
• MeydaniSNEndresSWoodsMMOral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older womenJ Nutr19911215475552007907
   PubMed Web of Science ®Google Scholar
• EndresSGhorbaniRKelleyVEThe effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cellsN Engl J Med19893202652712783477
   PubMed Web of Science ®Google Scholar
• LeeKWBlannADLipGYEffects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarctionThromb Res200611830531216154181
   PubMed Web of Science ®Google Scholar
• HansenJGrimsgaardSNordoyABonaaKHDietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activityThromb Res20009812313210713313
   PubMed Web of Science ®Google Scholar
• OliverMFOpieLHEffects of glucose and fatty acids on myocardial ischemia and arrhythmiasLancet19943431551587904009
   PubMed Web of Science ®Google Scholar
• NeelyJRGrotyohannLWRole of glycolytically derived protons and lactate and damage to the myocardium. Dissociation of adenosine triphosphate levels and recovery function of reperfused ischaemic heartsCirc Res1984558168246499136
   PubMed Web of Science ®Google Scholar
• WolffAARotmenschHHStanleyWCFerrariRMetabolic approaches to the treatment of ischaemic heart disease: the clinician’s perspectiveHeart Fail Rev2002718720311988642
   PubMedGoogle Scholar
• OliverMFSudden cardiac death: the lost fatty acid hypothesisQJM20069970170916935924
   PubMed Web of Science ®Google Scholar
• ShillingfordJFree noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarctionAm J Cardiol1967206056053508
   PubMed Web of Science ®Google Scholar
• PatelJVLeeKWTomsonJDubbKHughesEALipGYEffects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarctionInt J Cardiol2007115424516781788
   PubMed Web of Science ®Google Scholar
• McNultyPHComparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart diseaseAm J Physiol Heart Circ Physiol2000278H741H74710710341
   PubMed Web of Science ®Google Scholar
• RamelAMartinézAKielyMMoraisGBandarraNMThorsdottirIBeneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adultsDiabetologia2008511261126818491071
   PubMed Web of Science ®Google Scholar
• SirtoriCRPaolettiRManciniMN-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter StudyAm J Clin Nutr199765187418819174486
   PubMed Web of Science ®Google Scholar
• ToftIBonaaKHIngebretsenOCNordoyAJenssenTEffects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trialAnn Intern Med19951239119187486485
   PubMed Web of Science ®Google Scholar
• MillerMIs hypertriglyceridaemia an independent risk factor for coronary heart diseaseEur Heart J199819H18H229717060
   PubMed Web of Science ®Google Scholar
• ManninenVTenkanenLKoskinenPJoint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatmentCirculation19928537451728471
   PubMed Web of Science ®Google Scholar
• JeppesenJHeinMOSuadicaniPGyntelbergFTriglyceride concentration and ischaemic heart disease. An eight-year follow-up in the Copenhagen male studyCirculation199897102910369531248
   PubMed Web of Science ®Google Scholar
• SharrettARBallantyneCMCoadySACoronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions. The Atherosclerosis Risk In Communities (ARIC) studyCirculation20011041108111311535564
   PubMed Web of Science ®Google Scholar
• StampferMJKraussRMMaJA prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA19962768828888782637
   PubMed Web of Science ®Google Scholar
• HokansonJEAustinMAPlasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta analysis of population-based prospective studiesJ Cardiovasc Risk199632132998836866
   PubMedGoogle Scholar
• NordestgaardBGBennMSchnohrPTybjaerg-HansenANonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and womenJAMA200729829930817635890
   PubMed Web of Science ®Google Scholar
• RubinsHBRobinsSJCollinsDVeterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study GroupGemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterolN Engl J Med199934141041810438259
   PubMed Web of Science ®Google Scholar
• The BIP Study GroupSecondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) StudyCirculation2000102212710880410
   PubMed Web of Science ®Google Scholar
• MeadeTZuhrieRCookCCooperJMRC General Practice Research Framework, Bezafibrate in men with lower extremity arterial disease: randomised controlled trialBMJ20023251139114112433762
   PubMed Web of Science ®Google Scholar
• KeechASimesRJBarterPFIELD study investigatorsEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialLancet20053661849186116310551
   PubMed Web of Science ®Google Scholar
• DurringtonPNLipoproteins and their metabolismHyperlipidaemia, Diagnosis and Management2nd editionWright Publishers1989
   Google Scholar
• KruszynskaYTNormal metabolism: the physiology of fuel homeostasisPickupJWilliamsGTextbook of DiabetesBlackwell Science1997
   Google Scholar
• FraynKNNon esterified fatty acid metabolism and postprandial lipaemiaAtherosclerosis1998141SupplS41S469888641
   PubMedGoogle Scholar
• MeijssenSCastro CabezasMBallieuxCGMDerksenRJBilecenSErkelensDWInsulin mediated Inhibition of hormone sensitive lipase activity in vivo in relation to endogenous catecholamines in healthy subjectsJ Clin Endocrinol Metab2001864193419711549649
   PubMed Web of Science ®Google Scholar
• British Cardiac SocietyBritish Hypertension SocietyDiabetes UKHEART UKPrimary Care Cardiovascular SocietyStroke AssociationJBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practiceHeart200591Suppl 5v1v516365341
   PubMed Web of Science ®Google Scholar
• GrundySMBrewerHBJrCleemanJISmithSCJrLenfantCNational Heart, Lung, and Blood InstituteAmerican Heart AssociationDefinition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionCirculation200410943343814744958
   PubMed Web of Science ®Google Scholar
• FordESGilesWHDietzWHPrevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination SurveyJAMA200228735635911790215
   PubMed Web of Science ®Google Scholar
• LakkaHMLaaksonenDELakkaTAThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged menJAMA20022882709271612460094
   PubMed Web of Science ®Google Scholar
• IsomaaBAlmgrenPTuomiTCardiovascular morbidity and mortality associated with the metabolic syndromeDiabetes Care20012468368911315831
   PubMed Web of Science ®Google Scholar
• AlbertiKGMMZimmetPShawJfor the IDF Epidemiology Task Force Consensus GroupThe metabolic syndrome – a new worldwide definitionLancet20053661059106216182882
   PubMed Web of Science ®Google Scholar
• CarlsonLABöttigerLEIschaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective studyLancet197218658684111826
   PubMed Web of Science ®Google Scholar
• CastelliWPThe triglyceride issue: a view from FraminghamAm Heart J19861124324373739899
   PubMed Web of Science ®Google Scholar
• AbateNVegaGLGargAGrundySMAbnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDMAtherosclerosis19951181111228579621
   PubMed Web of Science ®Google Scholar
• StampferMJKraussRMMaJA prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA19962768828888782637
   PubMed Web of Science ®Google Scholar
• SimpsonHCMannJIMeadeTWChakrabartiRStirlingYWoolfLHypertriglyceridaemia and hypercoagulabilityLancet198317867906132131
   PubMed Web of Science ®Google Scholar
• ChadarevianRBruckertEDejagerSPresbergPTurpinGRelationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold valueThromb Res19999617518210588459
   PubMed Web of Science ®Google Scholar
• de ManFHNieuwlandRvan der LaarseAActivated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapyAtherosclerosis200015240741410998469
   PubMed Web of Science ®Google Scholar
• NordøyASvenssonBHansenJBAtorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemiaJ Thromb Haemost2003169069712871402
   PubMed Web of Science ®Google Scholar
• DurringtonPNBhatnagarDMacknessMIAn omega-3 poly-unsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemiaHeart20018554454811303007
   PubMed Web of Science ®Google Scholar
• SchwellenbachLJOlsonKLMcConnellKJStolcpartRSNashJDMerenichJAClinical Pharmacy Cardiac Risk Service Study GroupThe triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglyceridesJ Am Coll Nutr20062548048517229894
   PubMed Web of Science ®Google Scholar
• GrimsgaardSBonaaKHHansenJBNordøyAHighly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acidsAm J Clin Nutr1997666496599280188
   PubMed Web of Science ®Google Scholar
• MathersCDSteinCMa FatMThe Global Burden of Disease 2000 Study (version 2): Methods and Results Discussion Paper 50 Geneva: Global Program on Evidence for Health PolicyWorld Health Organization2002http://www.who.int/infobase IBRef: 19998.
   Google Scholar